Anti-Xa activity in patients with hepatocellular carcinoma
J Gastrointestin Liver Dis
.
2017 Mar;26(1):91-92.
doi: 10.15403/jgld.2014.1121.261.axa.
Authors
Christos Triantos
1
,
Andreas Emmanuil
2
,
Ioanna Aggeletopoulou
3
,
Chrysostomos Tsolias
3
,
Xristina Grigoropoulou
3
,
Eleni Jelastopulu
4
,
Nikolaos Koukias
3
,
Stelios Assimakopoulos
5
,
Charalambos Gogos
5
,
Chrisoula Labropoulou-Karatza
5
,
Konstantinos Thomopoulos
3
Affiliations
1
Department of Gastroenterology, University Hospital of Patras, Patras, Greece. chtriantos@hotmail.com.
2
Department of Hematology, University Hospital of Patras, Patras, Greece.
3
Department of Gastroenterology, University Hospital of Patras, Patras, Greece.
4
Department of Public Health, Medical School, University of Patras,Patras, Greece.
5
Department of Internal Medicine, University Hospital of Patras, Patras, Greece.
PMID:
28338119
DOI:
10.15403/jgld.2014.1121.261.axa
No abstract available
Publication types
Letter
MeSH terms
Adult
Aged
Aged, 80 and over
Carcinoma, Hepatocellular / blood*
Carcinoma, Hepatocellular / mortality
Factor Xa Inhibitors / blood*
Female
Humans
Liver Neoplasms / blood*
Liver Neoplasms / mortality
Male
Middle Aged
Substances
Factor Xa Inhibitors